COSCIENS Biopharma Inc.
CSCI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$15,309 | -$3,485 | $3,448 | $2,640 |
| Dep. & Amort. | $1,607 | $1,469 | $1,468 | $1,475 |
| Deferred Tax | $79 | -$885 | $1,080 | -$222 |
| Stock-Based Comp. | $464 | $192 | $69 | $14 |
| Change in WC | -$1,675 | $59 | -$936 | -$1,159 |
| Other Non-Cash | $266 | $95 | $100 | $5 |
| Operating Cash Flow | -$14,568 | -$2,582 | $5,229 | $2,753 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,161 | -$722 | -$304 | -$556 |
| Net Acquisitions | $26,037 | $0 | $0 | $1 |
| Inv. Purchases | $0 | $0 | -$1 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $207 | -$8 | $0 | -$64 |
| Investing Cash Flow | $25,083 | -$730 | -$304 | -$620 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$421 | -$370 | -$330 | -$262 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$8 | $13 | $63 | $21 |
| Financing Cash Flow | -$588 | -$357 | -$267 | $50,588 |
| Forex Effect | -$212 | $0 | $0 | $0 |
| Net Chg. in Cash | $9,715 | -$3,512 | $4,033 | $1,892 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,678 | $10,190 | $6,157 | $4,211 |
| End Cash | $16,393 | $6,678 | $10,190 | $6,103 |
| Free Cash Flow | -$15,729 | -$3,304 | $4,925 | $2,197 |